Literature DB >> 29283284

Endothelial dysfunction occurs independently of adipose tissue inflammation and insulin resistance in ovariectomized Yucatan miniature-swine.

Thomas J Jurrissen1, T Dylan Olver2, Nathan C Winn1, Zachary I Grunewald1, Gabriela S Lin1,3, Jessica A Hiemstra2, Jenna C Edwards2, Michelle L Gastecki1, Rebecca J Welly1, Craig A Emter2, Victoria J Vieira-Potter1, Jaume Padilla1,4,5.   

Abstract

In rodents, experimentally-induced ovarian hormone deficiency increases adiposity and adipose tissue (AT) inflammation, which is thought to contribute to insulin resistance and increased cardiovascular disease risk. However, whether this occurs in a translationally-relevant large animal model remains unknown. Herein, we tested the hypothesis that ovariectomy would promote visceral and perivascular AT (PVAT) inflammation, as well as subsequent insulin resistance and peripheral vascular dysfunction in female swine. At sexual maturity (7 months of age), female Yucatan mini-swine either remained intact (control, n = 9) or were ovariectomized (OVX, n = 7). All pigs were fed standard chow (15-20 g/kg), and were euthanized 6 months post-surgery. Uterine mass and plasma estradiol levels were decreased by ∼10-fold and 2-fold, respectively, in OVX compared to control pigs. Body mass, glucose homeostasis, and markers of insulin resistance were not different between control and OVX pigs; however, OVX animals exhibited greater plasma triglycerides and triglyceride:HDL ratio. Ovariectomy enhanced visceral adipocyte expansion, although this was not accompanied by brachial artery PVAT adipocyte expansion, AT inflammation in either depot, or increased systemic inflammation assessed by plasma C-reactive protein concentrations. Despite the lack of AT inflammation and insulin resistance, OVX pigs exhibited depressed brachial artery endothelial-dependent vasorelaxation, which was rescued with blockade of endothelin receptor A. Together, these findings indicate that in female Yucatan mini-swine, increased AT inflammation and insulin resistance are not required for loss of ovarian hormones to induce endothelial dysfunction.

Entities:  

Keywords:  Adipose inflammation; Animal Models; Endothelial function; Metabolism; Ovariectomy; Reproductive hormones; Vascular function; inflammation; insulin resistance; swine

Mesh:

Substances:

Year:  2017        PMID: 29283284      PMCID: PMC5915048          DOI: 10.1080/21623945.2017.1405191

Source DB:  PubMed          Journal:  Adipocyte        ISSN: 2162-3945            Impact factor:   4.534


  73 in total

1.  Aortic perivascular adipose-derived interleukin-6 contributes to arterial stiffness in low-density lipoprotein receptor deficient mice.

Authors:  Bing Du; An Ouyang; Jason S Eng; Bradley S Fleenor
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-04-03       Impact factor: 4.733

2.  Retention of sedentary obese visceral white adipose tissue phenotype with intermittent physical activity despite reduced adiposity.

Authors:  Katherine S Wainright; Nicholas J Fleming; Joe L Rowles; Rebecca J Welly; Terese M Zidon; Young-Min Park; T'Keaya L Gaines; Rebecca J Scroggins; Emily K Anderson-Baucum; Alyssa H Hasty; Victoria J Vieira-Potter; Jaume Padilla
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-07-15       Impact factor: 3.619

3.  Reduced adipose tissue inflammation represents an intermediate cardiometabolic phenotype in obesity.

Authors:  Melissa G Farb; Sherman Bigornia; Melanie Mott; Kahraman Tanriverdi; Kristine M Morin; Jane E Freedman; Lija Joseph; Donald T Hess; Caroline M Apovian; Joseph A Vita; Noyan Gokce
Journal:  J Am Coll Cardiol       Date:  2011-07-12       Impact factor: 24.094

4.  Comparative effects of estrogen, raloxifene and tamoxifen on endothelial dysfunction, inflammatory markers and oxidative stress in ovariectomized rats.

Authors:  Aline Zandonadi Lamas; Izabela Facco Caliman; Polyana Lima Meireles Dalpiaz; Antônio Ferreira de Melo; Glaucia Rodrigues Abreu; Elenice Moreira Lemos; Sonia Alves Gouvea; Nazaré Souza Bissoli
Journal:  Life Sci       Date:  2015-01-24       Impact factor: 5.037

5.  Oxidative stress increases synthesis of big endothelin-1 by activation of the endothelin-1 promoter.

Authors:  J Kähler; S Mendel; J Weckmüller; H D Orzechowski; C Mittmann; R Köster; M Paul; T Meinertz; T Münzel
Journal:  J Mol Cell Cardiol       Date:  2000-08       Impact factor: 5.000

6.  Endothelial nitric oxide synthase uncoupling and perivascular adipose oxidative stress and inflammation contribute to vascular dysfunction in a rodent model of metabolic syndrome.

Authors:  Chiara Marchesi; Talin Ebrahimian; Orlando Angulo; Pierre Paradis; Ernesto L Schiffrin
Journal:  Hypertension       Date:  2009-10-12       Impact factor: 10.190

7.  Triglycerides-to-HDL ratio as a new marker of endothelial dysfunction in obese prepubertal children.

Authors:  Tommaso de Giorgis; M Loredana Marcovecchio; Ilaria Di Giovanni; Cosimo Giannini; Valentina Chiavaroli; Francesco Chiarelli; Angelika Mohn
Journal:  Eur J Endocrinol       Date:  2013-12-21       Impact factor: 6.664

8.  Estrogen improved metabolic syndrome through down-regulation of VEGF and HIF-1α to inhibit hypoxia of periaortic and intra-abdominal fat in ovariectomized female rats.

Authors:  Jinwen Xu; Qiuling Xiang; Guiping Lin; Xiaodong Fu; Kewen Zhou; Ping Jiang; Shuhui Zheng; Tinghuai Wang
Journal:  Mol Biol Rep       Date:  2012-05-09       Impact factor: 2.316

9.  High ratio of triglycerides to HDL-cholesterol predicts extensive coronary disease.

Authors:  Protasio Lemos da Luz; Desiderio Favarato; Jose Rocha Faria-Neto; Pedro Lemos; Antonio Carlos Palandri Chagas
Journal:  Clinics (Sao Paulo)       Date:  2008-08       Impact factor: 2.365

10.  SWELL1 is a regulator of adipocyte size, insulin signalling and glucose homeostasis.

Authors:  Yanhui Zhang; Litao Xie; Susheel K Gunasekar; Dan Tong; Anil Mishra; William J Gibson; Chuansong Wang; Trevor Fidler; Brodie Marthaler; Aloysius Klingelhutz; E Dale Abel; Isaac Samuel; Jessica K Smith; Lei Cao; Rajan Sah
Journal:  Nat Cell Biol       Date:  2017-04-24       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.